RNY-derived small RNAs as biomarkers for atherosclerosis-related disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10208351
APP PUB NO 20160237500A1
SERIAL NO

15030275

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns an in vitro method of diagnosis or prognosis of an atherosclerosis-related disorder by detecting a small Y RNA (s-RNY), as well as the use of an inhibitor of s-RNY as a medicament against atherosclerosis-related disorders. The invention also concerns a method for screening for a compound suitable for the treatment of an atherosclerosis-related disorder.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)FRANCE FAVERGES HAUTE-SAVOIE
UNIVERSITE PAUL SABATIER TOULOUSE III118 ROUTE DE NARBONNE TOULOUSE 31400
UNIVERSITE DE NICE SOPHIA ANTIPOLISGRAND CHÂTEAU 28 AVENUE DE VALROSE NICE 06000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Martinez, Laurent Toulouse, FR 10 58
Repetto, Emanuela Nice, FR 1 3
Trabucchi, Michele Nice, FR 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 19, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 19, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00